BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

478 related articles for article (PubMed ID: 27474733)

  • 1. [Immune-mediated neuropathies].
    Stoll G; Reiners K
    Nervenarzt; 2016 Aug; 87(8):887-98. PubMed ID: 27474733
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Guillain Barré syndrome and other immune mediated neuropathies: diagnosis and classification.
    Eldar AH; Chapman J
    Autoimmun Rev; 2014; 13(4-5):525-30. PubMed ID: 24434363
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immune-mediated neuropathies.
    Kieseier BC; Mathey EK; Sommer C; Hartung HP
    Nat Rev Dis Primers; 2018 Oct; 4(1):31. PubMed ID: 30310069
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Recent aspects of acute and chronic inflammatory polyneuropathies: Guillain-Barré syndrome and chronic inflammatory demyelinating polyneuropathy].
    Pascual-Pascual SI
    Rev Neurol; 2002 Aug 1-15; 35(3):269-76. PubMed ID: 12235589
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immune-Mediated Neuropathies.
    Gwathmey KG; Smith AG
    Neurol Clin; 2020 Aug; 38(3):711-735. PubMed ID: 32703478
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Autoimmune neuropathies: diagnosis, treatment, and recent topics].
    Ueda M; Kusunoki S
    Brain Nerve; 2011 Jun; 63(6):549-55. PubMed ID: 21613658
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular, Electrophysiological, and Ultrasonographic Differences in Selected Immune-Mediated Neuropathies with Therapeutic Implications.
    Dziadkowiak E; Nowakowska-Kotas M; Rałowska-Gmoch W; Budrewicz S; Koszewicz M
    Int J Mol Sci; 2023 May; 24(11):. PubMed ID: 37298132
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Diagnosis of immune-mediated neuropathies].
    Diószeghy P
    Orv Hetil; 2011 Sep; 152(39):1560-8. PubMed ID: 21920842
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Validation of elevated levels of interleukin-8 in the cerebrospinal fluid, and discovery of new biomarkers in patients with GBS and CIDP using a proximity extension assay.
    Kmezic I; Gustafsson R; Fink K; Svenningsson A; Samuelsson K; Ingre C; Olsson T; Hansson M; Kockum I; Adzemovic MZ; Press R
    Front Immunol; 2023; 14():1241199. PubMed ID: 38077366
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acquired inflammatory demyelinating neuropathies.
    Ensrud ER; Krivickas LS
    Phys Med Rehabil Clin N Am; 2001 May; 12(2):321-34, ix. PubMed ID: 11345010
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neurofilament light chain and total tau in the differential diagnosis and prognostic evaluation of acute and chronic inflammatory polyneuropathies.
    Kmezic I; Samuelsson K; Finn A; Upate Z; Blennow K; Zetterberg H; Press R
    Eur J Neurol; 2022 Sep; 29(9):2810-2822. PubMed ID: 35638376
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of inflammatory and paraproteinemic neuropathies.
    Monaco S; Turri E; Zanusso G; Maistrello B
    Curr Drug Targets Immune Endocr Metabol Disord; 2004 Jun; 4(2):141-8. PubMed ID: 15180454
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical and pathophysiological implications of autoantibodies in autoimmune neuropathies.
    Collet R; Caballero-Ávila M; Querol L
    Rev Neurol (Paris); 2023 Oct; 179(8):831-843. PubMed ID: 36907709
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of chronic immune-mediated neuropathies: chronic inflammatory demyelinating polyradiculoneuropathy, multifocal motor neuropathy, and the Lewis-Sumner syndrome.
    Sederholm BH
    Semin Neurol; 2010 Sep; 30(4):443-56. PubMed ID: 20941678
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Immune-mediated neuropathies].
    Kusunoki S
    Rinsho Shinkeigaku; 2009 Nov; 49(11):956-8. PubMed ID: 20030259
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Clinical guideline review: Guillain-barre syndrome and chronic inflammatory demyelinating polyneuropathy].
    Mori K; Hattori N; Sobue G
    Nihon Naika Gakkai Zasshi; 2002 Aug; 91(8):2443-57. PubMed ID: 12373856
    [No Abstract]   [Full Text] [Related]  

  • 17. Treatment of Guillain-Barré syndrome and CIDP.
    van Doorn PA
    J Peripher Nerv Syst; 2005 Jun; 10(2):113-27. PubMed ID: 15958124
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cerebrospinal fluid findings in Guillain-Barré syndrome and chronic inflammatory demyelinating polyneuropathies.
    Illes Z; Blaabjerg M
    Handb Clin Neurol; 2017; 146():125-138. PubMed ID: 29110767
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment approaches for Guillain-Barré syndrome and chronic inflammatory demyelinating polyradiculoneuropathy.
    Lindenbaum Y; Kissel JT; Mendell JR
    Neurol Clin; 2001 Feb; 19(1):187-204. PubMed ID: 11471764
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diagnosis, epidemiology and treatment of inflammatory neuropathies.
    Baig F; Knopp M; Rajabally YA
    Br J Hosp Med (Lond); 2012 Jul; 73(7):380-5. PubMed ID: 22875431
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.